Decision aid for heart failure medications at heart clinics
Part of Heart & circulation clinical trials.
This study tests a conversation aid that helps you and your heart doctor make better decisions about heart failure medications. It may improve your care by making sure you understand your options.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are being seen at an outpatient heart function clinic for heart failure
- You are between 40 and 85 years old
- Your heart's pumping ability is 40% or less (measured by an ultrasound or other heart imaging)
- You live in British Columbia (or are attending a participating clinic in BC)
- You are not on dialysis and do not have severe kidney disease
- You are not receiving palliative care or living in a long-term care facility
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether extra teaching from a pharmacist, using a dashboard, helps people with heart failure stick to their medicine (sacubitril/valsartan). If you qualify, you'll get extra support to manage your heart failure better.
This trial tests an investigational medicine called CRD-4730 (taken as a pill) to see if it can improve heart function and symptoms in people with heart failure and a reduced pumping ability. It may help you feel better and slow the progression of your condition.
This study tests whether remote check-ins via phone or video can help safely increase heart failure medications to target doses. You'll use a device to share weight, blood pressure, and heart rate with your doctor, who will adjust your medicines based on how you're doing.
This study tests tools to help doctors and patients work together to start or adjust heart failure medicines. You may qualify if your heart's pumping strength is low and you are missing certain recommended medications.
This study evaluates how well doctors follow guidelines for treating heart failure with reduced ejection fraction (HFrEF). It aims to improve the quality of care you receive during your regular clinic visits over the next year.
This study looks at how well patients with heart failure and a weakened heart muscle (ejection fraction of 40% or lower) do when taking the recommended heart failure medications. The goal is to see if these treatments improve their heart function and quality of life.
Hear when a new Heart Failure With Reduced Ejection Fraction (HFrEF) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.